STUDY QUESTION: Is elevated late-follicular phase progesterone (EP) associated with a deleterious impact on embryo quality (EQ) and cumulative live birth rates (LBRs)?
Introduction
Although significant improvements have been achieved in ART, delivery rates remain around 30% per embryo transfer (ET) (Castelló et al., 2016) . Thus, as multiple treatment attempts are generally required to achieve a live-birth (LB), increasing efforts have been made to report IVF success rates as cumulative live-birth rates (CLBR) in order to provide patients with better prognostic information (Viardot-Foucault et al., 2015) .
The question whether the supra-physiological increase of serum progesterone (P) during ovarian stimulation (OS) may influence the success of ART has been a matter of much debate over the last 30 years. While some suggest that there is no association (Venetis et al., 2007; Requena et al., 2014; Martínez et al., 2016) , others have concluded that IVF pregnancy rates may be inversely related to serum P levels (Bosch et al., 2003; Venetis et al., 2013; Connell et al., 2016) . Recent studies have attempted to separate the possible effects that elevated P (EP) on the day of hCG administration may have on both the endometrium and embryo quality (EQ). Although there is robust evidence that EP induces significant endometrial gene expression and epigenetic changes which may affect endometrial receptivity (ER) (Labarta et al., 2011; Liu et al., 2017; Xiong et al., 2017) and immunetolerance (Arck and Hecher, 2013) , the association between EP and EQ remains still largely unknown. While it is generally suggested that EQ is not affected by EP (Melo, 2006; Xu et al., 2012; Liu et al., 2017; Xiong et al., 2017) , three recent studies have postulated that there may be a detrimental effect (Huang et al., 2016; Healy et al., 2017; Vanni et al., 2017) . However, these latter studies did not evaluate the actual reproductive potential of the embryos produced.
The possibility to predict LBRs after the fresh cycle and the subsequent frozen ET (FET) has two clinically important consequences: first, physicians may estimate more precisely both the short-and long-term likelihood of ART treatment success, providing more accurate information to couples; secondly, it may allow one to discern better to what extent EP influences both ER and EQ. Therefore, the aim of the current study was to investigate the influence of circulating P levels on embryo delivery potential by evaluating its effect on embryo utilization rates and the chances of LB following either the fresh ET or one of the subsequent FETs.
Materials and Methods

Study population and design
This was a retrospective, single-center cohort study including all women who underwent ICSI at our center between 2010 and 2015. Approval to retrieve and analyze the data was provided by the Ethics Committee of the Brussels University Hospital (BUN 143201733383). We included only patients who performed OS under GnRH antagonist suppression. In order to evaluate the oocyte maturation rate and minimize the effect of the known differences in terms of fertilization between conventional IVF and ICSI (Abdalmageed et al., 2015) , we included only patients who underwent ICSI. Patients who underwent both conventional IVF and ICSI within the same cycle were also excluded from the study. Furthermore, women with an unknown LB outcome, who underwent GnRH agonist triggering, who were acceptors of donated oocytes, who performed blastocyst biopsy for pre-implantation genetic diagnosis or underwent freeze-only cycles were excluded.
OS, pituitary suppression, cycle monitoring and ovulation triggering
As previously described (Santos-Ribeiro et al., 2014) , OS was initiated on Day 2 of the menstrual cycle with either recombinant FSH (rFSH) or highly purified hMG (hp-hMG). Pituitary down-regulation was performed with a daily administration of a GnRH antagonist starting from Day 7 of the menstrual cycle onwards. Whenever necessary, dose adjustments of rFSH/hp-hMG were performed according to ovarian response. As soon as three follicles ≥17 mm were observed during pelvic ultrasound, final oocyte maturation was triggered with either highly purified urinary hCG (5000 or 10 000 IU, according to female body weight and the physicians' preference) or 250 IU of recombinant hCG. Cumulus-oocyte complexes (COCs) were collected by transvaginal aspiration~36 h after the hCG administration. Intravaginal P was administered daily (200 mg thrice a day) for luteal phase support.
Insemination, EQ assessment and cryopreservation
Fertilization was assessed 16-18 h after ICSI by the presence of two pronuclei and, from then onwards, embryo development was evaluated daily until the transfer or cryopreservation of cleavage stage embryos (Day 3) or blastocysts (Days 5 and 6). Supernumerary embryos of good quality were cryopreserved by means of vitrification using a closed vitrification device with high-security straws (CBS-ViT-HS ® ; Cryobiosystems) in combination with dimethyl sulfoxide and ethylene glycol as cryoprotectants (Irvine Scientific Freeze Kit ® ; Irvine Scientific). EQ was classified similar to what is described in a previous study performed by De Munck et al. (2015) , with a minor update in the classification (good quality embryos included up to < 50% fragmentation). Day 3 embryos were evaluated on the basis of the number and symmetry of their blastomeres, percentage of fragmentation, vacuolization, granulation and multinucleation. Based on all these parameters, an EQ score was assigned to all normally fertilized embryos using a predefined algorithm, which is divided into four categories: excellent, good, moderate or poor. On Day 3, fresh embryos were considered eligible for transfer if at least four blastomeres were present with a maximum of 50% fragmentation. Blastocysts were scored according to the grading system developed by Gardner and Schoolcraft (1999) based on the expansion stage, the number of cells joining compaction or blastulation, and the appearance of the trophectoderm (TE) and inner cell mass (ICM). Fresh blastocysts were considered eligible for transfer if they reached at least the fully compacted stage.
The following embryos were considered eligible for cryopreservation: Day 3 embryos with ≥6 blastomeres and ≤50% fragmentation; Days 5 and 6, fully expanded or hatching blastocysts with a type A/B/C ICM and type A/B TE. After warming (Irvine Scientific Thaw Kit ® ; Irvine Scientific), Day 3 embryos were cultured overnight in blastocyst medium until being transferred the following day (Day 4). Survival was scored based on the number of surviving blastomeres. If >2 cells degenerated after warming, a surplus embryo was warmed if available. An embryo score was given on Day 4 at the moment of transfer: excellent, good, moderate or poor (Table I) . Furthermore, vitrified blastocyst (Days 5 and 6) ETs were performed on the day of warming. Survival was evaluated after warming based on the survival of all cells and the re-expansion of the blastocyst. Embryos were transferred on Day 3 or on Day 5 according to the decision of the treating physician.
FET endometrial preparation
FETs took place in either a natural or an artificial cycle. In a natural cycle (NC), ovulation occurred either spontaneously or was artificially triggered with hCG. In artificially supplemented cycles (HRT), preparation of the endometrium consisted of the sequential administration of estradiol (E 2 ) valerate and micronized vaginal P (van de Vijver et al., 2014).
P assessment immunoassay
Serum P was assessed on the day of hCG administration using a validated electrochemilluminescence immunoassay (Cobas 6000 ® , Roche) with a measured sensitivity and within assay coefficient of variation of 0.03 μg/l and <7%, respectively. The same assay was used during the full duration of the study and was regularly calibrated to minimize variation of the results associated with time and reagent batch renewal.
Main outcome measures
Our main outcome parameters were embryo utilization rate and LB after either the fresh or one of the subsequent frozen embryo transfers. Embryo utilization rate was defined as the total number of embryos transferred and cryopreserved per number of fertilized oocytes. LB was defined as the delivery of a liveborn >24 weeks (Zegers-Hochschild et al., 2017) and was calculated per cycle started and per embryo transfer.
Statistical analysis
Patients were categorized into three groups according to their hCG-day P levels: low (≤0.50 ng/ml), medium (0.51-1.49 ng/ml) and high (≥1.50 ng/ml). These thresholds were selected according to the cut-offs applied among previous studies (Bosch et al., 2010; Xu et al., 2012; Santos-Ribeiro et al., 2014) and a balance between the use of clinically relevant intervals that would divide our sample homogenously so as not to hinder the inter-interval statistical analysis. The groups were compared using multivariable generalized estimating equation (GEE) regression modeling (to account for the eventual clustering of cycles performed by the same patient) followed by exploratory pairwise comparisons whenever warranted. Additionally, maturation, fertilization and utilization rates, as well as embryo quality, were compared using mixed-effects multilevel regression analysis, accounting for correlated outcomes within fresh cycles performed in the same patient and also oocytes deriving from the same OS-ICSI cycle. LB outcomes were assessed using either multivariable GEE regression (for fresh LBR and CLBR) or mixed-effects multilevel analysis (for FETs after a failed fresh ET attempt) including the P levels categories as a predictor along with other potential confounders in each model according to the outcome being evaluated. We chose to adjust for potentially confounding variables either previously known to affect LBRs or that varied significantly between the study groups. That said, we adjusted for following variables in all regression models: female age and BMI, infertility factors (male, tubal, ovarian, endometriosis, uterine, other female or otherwise unexplained infertility), number of COCs retrieved and the embryo developmental stage at transfer (cleavage or blastocyst stage). Moreover, for fresh LB, we also included the total dose of OS, the circulating E 2 on the day of ovulation triggering, EQ and the number of embryos transferred. For the FETs after a failed fresh ET, we adjusted additionally for the number and quality of the embryos transferred and the type of FET cycle preparation (NC with spontaneous LH peak, NC with hCG-triggered ovulation, HRT).
Given the possible moderating effect of the number of oocytes retrieved on the potential effect of EP on CLBR, we included two additional supplemental analyses. First, we performed a sensitivity analysis evaluating the effect of each P level on CLBR. Then, we repeated the multivariable regression analysis for CLBR detailed before but this time also added an interaction term between serum P and the number of oocytes retrieved (Venetis et al., 2015) .
Results
A total of 3400 ICSI cycles, performed in 2492 patients, were included in the analysis (Fig. 1) . Patients' baseline characteristics are summarized in Table II , while information regarding cycle and crude pregnancy outcomes are reported in Table III . Women in the high P level group were generally younger and had a better ovarian response (Table II) . Furthermore, between-group comparisons showed that late-follicular E 2 levels (1049, 1509 and 1976 pg/ml, respectively) and the number of oocytes retrieved (5, 7 and 10, respectively) increased with increasing trigger P levels. Moreover, even though the maturation rates were comparable among the three groups, the number of cycles with no mature oocyte was significantly higher in the low P group, when compared to the medium P group. With regard to embryo development, there were less embryos on Day 3 in the low and high P groups. In terms of utilization rates, while these seemed to decrease linearly as P increased for Day 3 embryos (72.3, 63.0 and 45.4%, respectively), only the high P group remained associated with a significant decrease in utilization rates on Day 5 (48.8, 47.8 and 38.8%, respectively). The EQ has been reported in detail in the Supplementary Table SI. In the unadjusted analysis of the crude pregnancy outcomes of our sample (Table III) , LBRs for the fresh cycle (18.2, 28.7 and 24.9% per started cycle, respectively) and CLBRs (24.3, 36.5 and 35.1%, respectively) seemed to be significantly lower for the low P group when compared to both the medium and high P groups. Furthermore, although the number of FETs performed after a failed FET was significantly higher in the EP group (1.9, 1.9 and 2.4, respectively), the LBR per FET did not vary significantly. However, the adjusted analysis revealed that the high P group was associated with both hindered fresh LBR and CLBR when compared to the medium P group, as illustrated in Fig. 2. P level influence on LBR and CLBR when controlling for ovarian response A sensitivity analysis was performed for fresh LBRs and CLBRs according to the number of oocytes retrieved (Fig. 3) . In this analysis, we generally noted that the slope of increase in pregnancy outcomes became shallower as P levels raised. Specifically, while the low P level pregnancy outcomes improved steeply as the number of COCs increased, this positive effect of oocyte retrieval rate was not as pronounced for the medium and then high P groups. This observation of the unadjusted trends in CLBR generated the hypothesis that the detrimental effect of P on CLBR might be moderated by the number of oocytes retrieved. In order to confirm this hypothesis, we added an interaction term between trigger day P and the number of COCs retrieved to the multivariable regression model presented in Fig. 2 for CLBR (Venetis et al., 2015) . This analysis confirmed that EP seems to curtail the benefit of an increasing number of oocytes on CLBR (interaction coefficient −0.06; 95% confidence interval from −0.09 to −0.03; P < 0.001).
Discussion
Our study demonstrated that EP was associated with a decrease in embryo utilization rate. Furthermore, ovarian response seemed to be correlated with high P levels, which is usually associated with better CLBR (Drakopoulos et al., 2016) , as one would infer at first glance when assessing the unadjusted pregnancy outcomes. However, the Figure 1 Flowchart of cycles included in the analyses. The study sample has been divided in the three groups according to progestrerone (P) levels on the day of hCG administration (vertical grey blocks). For each step of the analysis we describe the cycles included (dark grey horizontal blocks). ET, embryo transfer. subsequent multivariable regression analyses confirmed that the CLBRs were lower in the high P group regardless of the number of oocytes retrieved.
Late-follicular EP during OS is a complex event with an unclear underlying mechanism. Several researchers have detailed the potential explanations for this phenomenon, such as the compounding effect of multi-follicular development (Venetis et al., 2007) or the supraphysiologic exposure of mature granulosa to FSH (Bosch et al., 2003) . More recently, Oktem et al. (2017) provided a molecular explanation for why serum P may be elevated during OS. Summarily, they proposed that exogenous FSH promotes granulosa cell P synthesis directly without luteinization by up-regulating the expression and increasing the activity of 3ß-hydroxysteroid dehydrogenase, the enzyme responsible for the conversion of pregnenolone into P.
Our data showed that the high P group had the lowest embryo utilization rate while having the highest ovarian response. These contradictory trends suggest that EP may be associated with a higher amount of embryo wastage, a finding which is consistent with two recent studies associating EP with a decrease in top-quality embryo formation rate (Huang et al., 2016; Vanni et al., 2017) . However, these previous analyses were limited by the fact that they did not evaluate the embryo LB delivery potential. on the right). The odds of a live birth (LB) were assessed using multivariable GEE regression analysis including the P levels categories as a predictor along with other potential confounders in each model according to the outcome being evaluated. Specifically, for fresh LB we included also the embryo stage at transfer (cleavage or blastocyst stage), embryo quality (EQ) (EQ1, EQ2, EQ3-4), number of embryos transferred (single embryo vs multiple embryos) and the continuous variables female age and number of cumulus oocyte complexes (COCs) retrieved. For the frozen embryo transfer (FET) after a failed fresh embryo transfer we adjusted female age, number of COC retrieved, number of embryos transferred and the type of FET cycle preparation (natural cycle (NC) with spontaneous LH peak, NC with ovulation triggered using hCG, HRT). Finally, for cumulative live births (CLBR), we controlled for the following variables: female age, number of COC retrieved and stage of the embryos transferred.
Until now, most investigators evaluated the influence of EP focusing on fresh ET cycles (Santos-Ribeiro et al., 2014; Venetis et al., 2015) with only one study exploring the potential influence on CLBR (Bu et al., 2014) . In the present study, we evaluated both LBR and CLBR, thus increasing the clinical applicability of the results. Moreover, despite failing to show a significant decrease in FET LB rates, the number of FET cycles after a failed fresh ET in the high P group was significantly higher. Collectively, what one observes is that, despite having, on average, a better ovarian response and a younger age, the high P group still seems to fail to reach the best LBR and CLBR that one would expect this group to have. Venetis et al. (2015) proposed that the number of oocytes retrieved and late-follicular P levels affect IVF outcomes independently, given that they failed to find any effect-modifying interaction between both variables. Since CLBR accounts for the net-effect of P and ovarian response over multiple ETs, we were especially interested to see whether this hypothesis still held true when using CLBR as the outcome of interest. Contrary to the results presented by Venetis et al. (2015) , our analysis suggested that EP does seems to curtail the benefit of an increasing number of oocytes on CLBR, by an effect-modifying interaction. Specifically, in our unadjusted analysis, the overall CLBRs of the high P group did not vary significantly from the medium P level group. Furthermore, when we performed the confounder-adjusted analysis, we found a significant decrease in the CLBR for the high P level group.
The main weaknesses of the study were its retrospective nature and the fact that is was restricted to patients who performed ICSI in an GnRH antagonist protocol, limiting the extrapolation of the results to other treatment protocols. Furthermore, in order to minimize the potential for confounding, we adjusted our analysis for multiple variables. However, as not all potential confounders were present in our database (e.g. female smoking habits), it is possible that our results may still be biased. Finally, despite frequently being suggested as the most suitable benchmark for an IVF program, the use of CLBR as a pregnancy outcome is challenging given the lack of universal agreement on which are the best numerators and denominators to be used (Maheshwari et al., 2015) . We chose to evaluate the first LB of all embryos deriving from a single oocyte retrieval cycle, given that we wanted to assess how P production during the OS impacted that cycle specifically. That said, our results should not be extrapolated to subsequent OS cycles or to multiple subsequent LBs within the same IVF cycle.
Does the freeze-only strategy circumvent the negative impact of EP?
EP adversely affects implantation by impairing ER (Labarta et al., 2011; Liu et al., 2017; Xiong et al., 2017) , leading one to consider that this issue may be, at least partially, amenable by elective embryo cryopreservation. However, the negative influence that EP may also have on embryo utilization and CLBR may put this generalized assumption into question. In light of the above, the multidirectional impact of EP levels on IVF may deem the freeze-all strategy insufficient to solve the problem at hand. We believe that further studies are required in order to evaluate the potential benefit of other additional measures to minimize further the consequences of EP. Specifically, one potential solution could be to lower the total dose of OS (Bosch et al., 2010 , Venetis et al., 2016 . Although this strategy would likely reduce P production, the possibility that it could also reduce the number of oocytes retrieved should also be taken into consideration (Alper and Fauser, 2017) . To this extent, although the previous evidence has been inconsistent (Out et al., 2000; Hoomans et al., 2002; Tan et al., 2003; Klinkert et al., 2005; Sterrenburg et al., 2011) , some studies have shown a direct association between the total gonadotropin dose and oocyte retrieval rates. If this relationship is to be confirmed, while one could argue that a small decrease in OS and the number of oocyte retrieved might have little direct effect in the immediate fresh ET (Sunkara et al., 2011) , it may hinder long-term pregnancy rates, namely CLBR, as recent studies have demonstrated (Ji et al., 2013; Vaughan et al., 2017) . That said, a stepdown approach may be a better alternative, given the fact that both P's production and function seem to be concentrated on the late-follicular phase (Massin, 2017) . Nonetheless, this hypothesis requires further confirmation. Another approach to prospectively evaluate the effect of the total dose of stimulation on EQ and ER would be to perform a cross-over study in which oocyte donors would undergo two stimulation cycles with different ovulation triggering points (e.g. when ≥3 follicles of ≥17 vs ≥20 mm are present). This would effectively prolong the period of OS associated with the largest amount of P production and evaluate separately its effect on ER (by performing endometrial biopsies in both scenarios) and EQ (by comparing the utilization rates and pregnancy outcomes of the oocyte recipients). Such a study may assist physicians to establish the balance between the highest possible number of oocytes retrieved at the lowest possible level of circulating P.
In conclusion, our analysis offers evidence that high serum P levels at the end of the follicular phase are associated with a decrease in embryo utilization rates and CLBR.
